Bo Zhu
Guangxi Key Laboratory Of Regenerative Medicine, NanningGuangxi
530021, China
530021, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
METTL3-mediated m6A modification of CACNA1E promotes osteosarcoma progression and chemoresistance by enhancing WNT7B-mediated Ca2+ signaling.
Journal: Molecular cancer
Published: July 13, 2025
Extracellular vesicle-derived lncRNA VIM-AS1 promotes diabetic wound healing by promoting glycolysis and alleviating cellular senescence.
Journal: Stem cell research & therapy
Published: February 20, 2025
Investigation of cellular communication and signaling pathways in tumor microenvironment for high TP53-expressing osteosarcoma cells through single-cell RNA sequencing.
Journal: Medical oncology (Northwood, London, England)
Published: December 18, 2023
Identification of key genes involved in collagen hydrogel-induced chondrogenic differentiation of mesenchymal stem cells through transcriptome analysis: the role of m6A modification.
Journal: Journal of materials science. Materials in medicine
Published: July 16, 2023
Hsa_circ_0007031 promotes the proliferation and migration of osteosarcoma cells by sponging miR-196a-5p to regulate the HOXB6.
Journal: Biochemical pharmacology
Published: April 12, 2023
Identification of Candidate MicroRNA-mRNA Subnetwork for Predicting the Osteosarcoma Progression by Bioinformatics Analysis.
Journal: Computational and mathematical methods in medicine
Published: February 16, 2022
Analysis and identification of m6A RNA methylation regulators in metastatic osteosarcoma.
Journal: Molecular therapy. Nucleic acids
Published: April 05, 2021
Prognostic Implications of the Complement Protein C1Q and Its Correlation with Immune Infiltrates in Osteosarcoma.
Journal: OncoTargets and therapy
Published: December 03, 2020
Showing 1-8 of 8
Last Updated: 09/26/2026